Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PBLD |
| Upstream (Parents) |
|---|
| (<<) ADH6 → PBLD |
| Downstream (Children) |
|---|
| PBLD → SMR3A///SMR3B (>>) |
| PBLD → CES2 (>>) |
| PBLD → CDHR2 (>>) |
| PBLD → CAT (>>) |
| PBLD → ALAD (>>) |
| PBLD → SLC19A3 (>>) |
| PBLD → SELENBP1 (>>) |
| PBLD → UGT2B17 (>>) |
| PBLD → CALB1 (>>) |
| PBLD → FMO5 (>>) |
